Literature DB >> 30862301

Relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt.

Terresa J Eun1, Amresh Hanchate2, Anny T Fenton3,4, Jack A Clark2, Marisa N Aurora2,5, Mari-Lynn Drainoni2,5,6, Rebecca B Perkins2,7.   

Abstract

We described the relative contributions of parental intention and provider recommendation style to HPV and meningococcal vaccine receipt. Parent-child dyads that were eligible for both meningococcal and HPV vaccines participated in pre-visit surveys and consented to audio recording of their clinical interactions with healthcare providers related to vaccination. Surveys were analyzed for parent and child demographics and parental intention to vaccinate children with HPV and/or meningococcal vaccines. Audio recordings were analyzed for provider recommendation style, defined as indicated (provider stated vaccine was due at that visit) or not, and for child receipt of vaccines. Linear and logistic regression models were used to determine the relative contributions of parental intention and provider recommendation style to vaccine receipt. 56 parents/child dyads participated. 79% of children received HPV vaccines, and 93% received meningococcal vaccines. After controlling for demographic variables, parental intention did not differ by vaccine type. However, providers were less likely to use an indicated recommendation for HPV than for meningococcal vaccine. After controlling for demographic factors, parental intention, and provider recommendation style, vaccine type (HPV or meningococcal) was no longer associated with vaccine receipt Differences that were previously attributed to vaccine-specific factors may be explained by parents' and providers' roles in vaccine receipt. These findings suggest that interventions and policy recommendations regarding adolescent vaccination should focus on increasing parental demand for vaccines and ensuring that providers present all vaccines as the medical standard of care.

Entities:  

Keywords:  HPV Vaccine; meningococcal vaccine; parental intention; provider recommendation

Mesh:

Substances:

Year:  2019        PMID: 30862301      PMCID: PMC6816419          DOI: 10.1080/21645515.2019.1591138

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  38 in total

1.  An Educational Intervention to Improve HPV Vaccination: A Cluster Randomized Trial.

Authors:  Brian E Dixon; Gregory D Zimet; Shan Xiao; Wanzhu Tu; Brianna Lindsay; Abby Church; Stephen M Downs
Journal:  Pediatrics       Date:  2018-12-10       Impact factor: 7.124

2.  Advancing Human Papillomavirus Vaccine Delivery: 12 Priority Research Gaps.

Authors:  Paul L Reiter; Mary A Gerend; Melissa B Gilkey; Rebecca B Perkins; Debbie Saslow; Shannon Stokley; Jasmin A Tiro; Gregory D Zimet; Noel T Brewer
Journal:  Acad Pediatr       Date:  2018-03       Impact factor: 3.107

3.  Missed opportunities for HPV vaccination in adolescent girls: a qualitative study.

Authors:  Rebecca B Perkins; Jack A Clark; Gauri Apte; Jessica L Vercruysse; Justen J Sumner; Constance L Wall-Haas; Anna W Rosenquist; Natalie Pierre-Joseph
Journal:  Pediatrics       Date:  2014-09       Impact factor: 7.124

4.  Predictors of parents' willingness to vaccinate for human papillomavirus and physicians' intentions to recommend the vaccine.

Authors:  Jessica L Barnack; Diane M Reddy; Carolyne Swain
Journal:  Womens Health Issues       Date:  2010 Jan-Feb

5.  Human Papillomavirus (HPV) Vaccination Motivators, Barriers, and Brochure Preferences Among Parents in Multicultural Hawai'i: a Qualitative Study.

Authors:  May Rose Isnec Dela Cruz; Jo Ann Umilani Tsark; John Jiangtian Chen; Cheryl Lynn Albright; Kathryn Lenzner Braun
Journal:  J Cancer Educ       Date:  2017-09       Impact factor: 2.037

6.  Announcements Versus Conversations to Improve HPV Vaccination Coverage: A Randomized Trial.

Authors:  Noel T Brewer; Megan E Hall; Teri L Malo; Melissa B Gilkey; Beth Quinn; Christine Lathren
Journal:  Pediatrics       Date:  2016-12-05       Impact factor: 7.124

7.  Quality of physician communication about human papillomavirus vaccine: findings from a national survey.

Authors:  Melissa B Gilkey; Teri L Malo; Parth D Shah; Megan E Hall; Noel T Brewer
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-10-22       Impact factor: 4.254

8.  Providers' perceptions of parental concerns about HPV vaccination.

Authors:  Rebecca B Perkins; Jack A Clark
Journal:  J Health Care Poor Underserved       Date:  2013-05

Review 9.  Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature.

Authors:  Dawn M Holman; Vicki Benard; Katherine B Roland; Meg Watson; Nicole Liddon; Shannon Stokley
Journal:  JAMA Pediatr       Date:  2014-01       Impact factor: 16.193

Review 10.  Preventing Cervical Cancer in the United States: Barriers and Resolutions for HPV Vaccination.

Authors:  Anna Louise Beavis; Kimberly L Levinson
Journal:  Front Oncol       Date:  2016-02-01       Impact factor: 6.244

View more
  3 in total

1.  Effect of a multi-component intervention on providers' HPV vaccine communication.

Authors:  Rebecca B Perkins; Bolanle Banigbe; Anny T Fenton; Amanda K O'Grady; Emily M Jansen; Judith L Bernstein; Natalie P Joseph; Terresa J Eun; Dea L Biancarelli; Mari-Lynn Drainoni
Journal:  Hum Vaccin Immunother       Date:  2020-05-13       Impact factor: 3.452

2.  Effect of provider recommendation style on the length of adolescent vaccine discussions.

Authors:  Anny T H R Fenton; Chelsea Orefice; Terresa J Eun; Dea Biancarelli; Amresh Hanchate; Mari-Lynn Drainoni; Rebecca B Perkins
Journal:  Vaccine       Date:  2021-01-12       Impact factor: 3.641

3.  Disparities in Healthcare Providers' Recommendation of HPV Vaccination for U.S. Adolescents: A Systematic Review.

Authors:  Wei Yi Kong; Gabriela Bustamante; Isabella K Pallotto; Marjorie A Margolis; Rebecca Carlson; Annie-Laurie McRee; Melissa B Gilkey
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-23       Impact factor: 4.254

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.